NEW YORK, Oct. 21 (GenomeWeb News) - Genaissance Pharmaceuticals will provide high-throughput genotyping services to Pyxis Genomics, a Chicago-based animal health-services company, the firms said today.
The collaboration addresses an emerging market using genomic technology to document and identify food products throughout the production chain for safety purposes, and to help producers streamline costs.
Terms of the agreement call for Pyxis to pay Genaissance a fee for each test it performs. In addition, the companies will co-commercialize the Pyxis Profile-1 System, a panel of SNPs and related software and databases developed by IBM Life Sciences.
The companies said they have validated the assays to be used in this process, and expect to receive commercial samples.
Further details were not disclosed.